Aerovate Therapeutics Inc (AVTE)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more
Ask ADVFN Intelligence (AI)
Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 1, 2024 NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.04 | 1.5444015444 | 2.59 | 2.64 | 2.45 | 326665 | 2.54353309 | CS |
| 4 | 0.0192 | 0.735406771871 | 2.6108 | 2.71 | 2.45 | 188578 | 2.57259862 | CS |
| 12 | 0.52 | 24.644549763 | 2.11 | 3 | 1.95 | 799232 | 2.48300976 | CS |
| 26 | 1.17 | 80.1369863014 | 1.46 | 3 | 1.36 | 606203 | 2.20001094 | CS |
| 52 | -18.59 | -87.6060320452 | 21.22 | 32.415 | 1.25 | 555723 | 4.69832133 | CS |
| 156 | -7.6 | -74.2913000978 | 10.23 | 32.415 | 1.25 | 243353 | 7.85440026 | CS |
| 260 | -25.37 | -90.6071428571 | 28 | 32.415 | 1.25 | 227164 | 8.54929801 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
